File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Diagnostic value of prostate imaging - reporting and data system (PI-RADS) version 2 in the Chinese population: a correlation study with magnetic resonance imaging (MRI)/ultrasound (US) fusion targeted biopsy

TitleDiagnostic value of prostate imaging - reporting and data system (PI-RADS) version 2 in the Chinese population: a correlation study with magnetic resonance imaging (MRI)/ultrasound (US) fusion targeted biopsy
Authors
Issue Date2017
PublisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/
Citation
22nd Annual Scientific Meeting of the Hong Kong Urological Association, Hong Kong, 20 November 2016. In BJU International, 2017, v. 119 n. suppl. 3, p. 9 How to Cite?
AbstractObjective: To evaluate the diagnosticvalue of Prostate Imaging – Reporting andData System (PI-RADS) version 2 in MRIprostate in a Chinese cohort.Patients and Methods: From July 2015to July 2016, 94 Chinese men with ele-vated serum prostate-specific antigen(PSA) of 4–20 ng/mL underwent pre-biopsy multiparametric MRI prostatewith a 1.5T MRI scanner. A panel of 3genitourinary radiologists assignedregions of interests (ROIs) according tothe PI-RADS v2. Those having PI-RADSGrade 2–5 lesion(s) underwent MRI/USfusion targeted biopsy using the Arte-misTMfusion platform.Results: A total of 132 PI-RADS 2–5lesions were detected in 81 patients(mean 1.71.0 lesions per patient). Can-cer detection rates (CDRs) for PI-RADS2, 3, 4 and 5 lesions were 0% (0/44),9.8% (5/51), 34.5% (10/29) and 50.0%(4/8) respectively. For PI-RADS 3–5lesions, 34.1% (30/88) and 65.9% (58/88)were located at the transition andperipheral zones respectively, with nodifference in CDRs at the two sites (30%vs 17.2%, p = 0.18). CDR of clinicallysignificant cancers was signi ficantlyhigher for PI-RADS 4–5 lesions com-pared with PI-RADS 3 lesions (35.1% vs7.8%, p = 0.002).Conclusion: PI-RADS v2 has good corre-lation with biopsy outcomes and can beused as risk-strati fication tool for selectingpatients for targeted biopsy.
DescriptionAbstract
Persistent Identifierhttp://hdl.handle.net/10722/241667
ISSN
2017 Impact Factor: 4.688
2015 SCImago Journal Rankings: 2.009

 

DC FieldValueLanguage
dc.contributor.authorMa, WK-
dc.contributor.authorLai, ASH-
dc.contributor.authorLam, KC-
dc.contributor.authorYip, LKC-
dc.contributor.authorHo, SHB-
dc.contributor.authorWong, JKW-
dc.contributor.authorWong, CKW-
dc.contributor.authorLai, TCT-
dc.contributor.authorTsang, CF-
dc.contributor.authorNg, ATL-
dc.contributor.authorTsu, HLJ-
dc.contributor.authorYiu, MK-
dc.date.accessioned2017-06-20T01:46:54Z-
dc.date.available2017-06-20T01:46:54Z-
dc.date.issued2017-
dc.identifier.citation22nd Annual Scientific Meeting of the Hong Kong Urological Association, Hong Kong, 20 November 2016. In BJU International, 2017, v. 119 n. suppl. 3, p. 9-
dc.identifier.issn1464-4096-
dc.identifier.urihttp://hdl.handle.net/10722/241667-
dc.descriptionAbstract-
dc.description.abstractObjective: To evaluate the diagnosticvalue of Prostate Imaging – Reporting andData System (PI-RADS) version 2 in MRIprostate in a Chinese cohort.Patients and Methods: From July 2015to July 2016, 94 Chinese men with ele-vated serum prostate-specific antigen(PSA) of 4–20 ng/mL underwent pre-biopsy multiparametric MRI prostatewith a 1.5T MRI scanner. A panel of 3genitourinary radiologists assignedregions of interests (ROIs) according tothe PI-RADS v2. Those having PI-RADSGrade 2–5 lesion(s) underwent MRI/USfusion targeted biopsy using the Arte-misTMfusion platform.Results: A total of 132 PI-RADS 2–5lesions were detected in 81 patients(mean 1.71.0 lesions per patient). Can-cer detection rates (CDRs) for PI-RADS2, 3, 4 and 5 lesions were 0% (0/44),9.8% (5/51), 34.5% (10/29) and 50.0%(4/8) respectively. For PI-RADS 3–5lesions, 34.1% (30/88) and 65.9% (58/88)were located at the transition andperipheral zones respectively, with nodifference in CDRs at the two sites (30%vs 17.2%, p = 0.18). CDR of clinicallysignificant cancers was signi ficantlyhigher for PI-RADS 4–5 lesions com-pared with PI-RADS 3 lesions (35.1% vs7.8%, p = 0.002).Conclusion: PI-RADS v2 has good corre-lation with biopsy outcomes and can beused as risk-strati fication tool for selectingpatients for targeted biopsy.-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/-
dc.relation.ispartofBJU International-
dc.rightsPreprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article]. Authors are not required to remove preprints posted prior to acceptance of the submitted version. Postprint This is the accepted version of the following article: [full citation], which has been published in final form at [Link to final article].-
dc.titleDiagnostic value of prostate imaging - reporting and data system (PI-RADS) version 2 in the Chinese population: a correlation study with magnetic resonance imaging (MRI)/ultrasound (US) fusion targeted biopsy-
dc.typeConference_Paper-
dc.identifier.emailMa, WK: mwk054@hku.hk-
dc.identifier.emailHo, SHB: hobrian@hku.hk-
dc.identifier.emailTsu, HLJ: jamestsu@hku.hk-
dc.identifier.emailYiu, MK: pmkyiu@hku.hk-
dc.identifier.doi10.1111/bju.13768-
dc.identifier.hkuros272636-
dc.identifier.volume119-
dc.identifier.issuesuppl. 3-
dc.identifier.spage9-
dc.identifier.epage9-
dc.publisher.placeUnited Kingdom-
dc.customcontrol.immutablecsl 170718-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats